Sulfasalazine NDC 62135-960

NDC codes

FDA NDC Directory

Product NDC (as listed)62135-960Labeler and product segments. Claims need a package NDC.

Product NDC at billing width62135-0960Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
62135-960-01	62135096001	100 TABLET in 1 BOTTLE (62135-960-01)Marketed from May 7, 2021
62135-960-05	62135096005	500 TABLET in 1 BOTTLE (62135-960-05)Marketed from May 7, 2021
62135-960-10	62135096010	1000 TABLET in 1 BOTTLE (62135-960-10)Marketed from May 7, 2021
62135-960-31	62135096031	300 TABLET in 1 BOTTLE (62135-960-31)Marketed from May 7, 2021

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Sulfasalazine
Generic name (nonproprietary): sulfasalazine
Active ingredients: Sulfasalazine — 500 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Chartwell RX, LLC.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 080197
Marketing start: Nov 12, 1973
Listing expires: Dec 31, 2026
Other FDA classes: Aminosalicylic Acids (Chemical structure)
Identifiers: Product ID 62135-960_ef9f56ad-c921-6fe7-e053-2a95a90a85afSPL ID ef9f56ad-c921-6fe7-e053-2a95a90a85afSPL set ID 029716bd-ee1a-484c-bf1f-ec8d02d5281bRxCUI 198232UNII 3XC8GUZ6CBUPC 0362135960018, 0362135960056, 0362135960315, 0362135960100
Pharmacologic class: Aminosalicylate

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N462135096001 followed by a unit qualifier and the quantity

Package 62135-0960-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 12, 2022.

Indications (excerpt from the label)

INDICATIONS AND USAGE Sulfasalazine Tablets are indicated: a) in the treatment of mild to moderate ulcerative colitis, and as adjunctive therapy in severe ulcerative colitis; and b) for the prolongation of the remission period between acute attacks of ulcerative colitis.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)